Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP265631.RAGM1dxlHRpeb1MlhQyAMTW2-lCFdaM9eAuZU1tK9p1pc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP265631.RAGM1dxlHRpeb1MlhQyAMTW2-lCFdaM9eAuZU1tK9p1pc130_assertion type Assertion NP265631.RAGM1dxlHRpeb1MlhQyAMTW2-lCFdaM9eAuZU1tK9p1pc130_head.
- NP265631.RAGM1dxlHRpeb1MlhQyAMTW2-lCFdaM9eAuZU1tK9p1pc130_assertion description "[We investigated genetically affected leukemic cells in FIP1L1-PDGFRA+ chronic eosinophilic leukemia (CEL) and in BCR-ABL1+ chronic myeloid leukemia (CML), two myeloproliferative disorders responsive to imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP265631.RAGM1dxlHRpeb1MlhQyAMTW2-lCFdaM9eAuZU1tK9p1pc130_provenance.
- NP265631.RAGM1dxlHRpeb1MlhQyAMTW2-lCFdaM9eAuZU1tK9p1pc130_assertion evidence source_evidence_literature NP265631.RAGM1dxlHRpeb1MlhQyAMTW2-lCFdaM9eAuZU1tK9p1pc130_provenance.
- NP265631.RAGM1dxlHRpeb1MlhQyAMTW2-lCFdaM9eAuZU1tK9p1pc130_assertion SIO_000772 17215855 NP265631.RAGM1dxlHRpeb1MlhQyAMTW2-lCFdaM9eAuZU1tK9p1pc130_provenance.
- NP265631.RAGM1dxlHRpeb1MlhQyAMTW2-lCFdaM9eAuZU1tK9p1pc130_assertion wasDerivedFrom befree-20150227 NP265631.RAGM1dxlHRpeb1MlhQyAMTW2-lCFdaM9eAuZU1tK9p1pc130_provenance.
- NP265631.RAGM1dxlHRpeb1MlhQyAMTW2-lCFdaM9eAuZU1tK9p1pc130_assertion wasGeneratedBy ECO_0000203 NP265631.RAGM1dxlHRpeb1MlhQyAMTW2-lCFdaM9eAuZU1tK9p1pc130_provenance.